Loading the records…
Loading the records…
S. 3557 is an early-stage procedural bill that prohibits federal funds from implementing a specific December 2025 AI executive order. With only two actions (introduction and referral) and no hearings, markup, or companion legislation, its near-term market impact is negligible. No specific companies or sectors face direct revenue consequences from this bill in its current form.
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
No market implications at this time. The bill is in the earliest legislative stage with no signals of advancement. Retail investors should monitor for committee hearings or a House companion bill as triggers for reassessment, but currently this is a non-event for all AI-related equities.
S. 3557, the States' Right to Regulate AI Act, was introduced on December 17, 2025, by Sen. Markey (D-MA) with 10 cosponsors. The bill would prohibit the use of federal funds to implement the Executive Order titled 'Ensuring a National Policy Framework for Artificial Intelligence' issued on December 11, 2025. The bill has been read twice and referred to the Committee on Commerce, Science, and Transportation, where it remains with no further action. As an early-stage authorization bill with no appropriation attached, it changes no current law or regulation. The executive order it targets is not described in the provided text, so the substantive impact of the prohibition is speculative. The bill's text is a single operative section blocking funds for implementation, administration, or enforcement of that executive order. There is no funding mechanism, no tax credit, no grant program, and no procurement directive. The low cosponsor count (10), absence of committee leadership as sponsors, and lack of legislative velocity (only two actions on one day) indicate minimal momentum. No committee hearings, markup sessions, or reported versions are recorded. Without a companion bill in the House, path to passage requires reintroduction and advancement in both chambers. For retail investors, this bill represents legislative noise. It does not alter the competitive landscape for any publicly traded company. AI-related equities — including pure plays like Palantir (PLTR), C3.ai (AI), and diversified tech firms such as Microsoft (MSFT), Alphabet (GOOGL), NVIDIA (NVDA), and AMD (AMD) — face no direct revenue or cost impact from this bill at this stage. The only conceivable long-term scenario requiring monitoring would be if similar language advanced through committee and gained bipartisan support, potentially limiting federal AI coordination, but that path has not materialized.
Matched on shared policy language across AI analyses, with ticker & timing weight
Executive orders & memoranda affecting the same sectors or companies
The President invokes Section 232 of the Trade Expansion Act to declare that imports of robotics, industrial machinery, and their components threaten national security, and directs the Secretary of Commerce and USTR to negotiate agreements with trading partners to adjust these imports, potentially leading to tariffs or quotas within 180 days.
This proclamation initiates negotiations to adjust imports of wind turbines and their components under Section 232, citing national security concerns including cybersecurity vulnerabilities, radar interference, and grid reliability. It does not immediately impose tariffs but sets the stage for potential trade restrictions, and notes that certain wind turbine components made of aluminum, steel, or copper are already subject to existing tariffs.
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →